Please log in to view this page
Username
Password
A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
The investigators are looking for a better way to prevent cervical cancer. This study is comparing two different methods to...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
